GRIMALDI CLAUDIA bought IGC
April 1, 2026 · Form 4 insider transaction
GRIMALDI CLAUDIA bought 138,462 shares of IGC Pharma, Inc. at $0.26 per share, a transaction worth $36.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
138,462
Price
$0.26
Total value
$36.0K
InsiderGRIMALDI CLAUDIA
Role—
CompanyIGC Pharma, Inc. (IGC)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 1, 2026
Filing dateApril 6, 2026
Shares owned after1,372,714
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024.